Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy

Journal of NeuroVirology

Volumn 21, Issue 6, 2015, Pages 666-670

  Giovannelli, Irene ^a   Martelli, Francesco ^a   Repice, Anna ^b   Massacesi, Luca ^b,c   Azzi, Alberta ^a   Giannecchini, Simone ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Exosomes; JCPyV; MicroRNA expression; Multiple sclerosis; Natalizumab; PML

Indexed keywords

MICRORNA; NATALIZUMAB; VIRUS RNA; IMMUNOLOGIC FACTOR;

ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; EXOSOME; GENOMICS; HUMAN; JC VIRUS; MULTIPLE SCLEROSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; URINALYSIS; VIRUS DETECTION; BLOOD; GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URINE; VIROLOGY;

HUMANS; IMMUNOLOGIC FACTORS; JC VIRUS; MICRORNAS; MULTIPLE SCLEROSIS; NATALIZUMAB; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 84946479027     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-015-0325-3     Document Type: Article

References (20)

1. Bauman Y, Mandelboim O (2011) MicroRNA based immunoevasion mechanism of human polyomaviruses. RNA Biol 8:591–594
2. Bauman Y, Nachmani D, Vitenshtein A, Tsukerman P, Drayman N, Stern-Ginossar N, Lankry D, Gruda R, Mandelboim O (2011) An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell Host Microbe 9:93–102
3. Bloomgren G, Richman S, Hotermans C, Subramanyam M, Goelz S, Natarajan A, Lee S, Plavina T, Scanlon JV, Sandrock A, Bozic C (2012) Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med 366:1870–1880
4. Boss IW, Renne R (2011) Viral miRNAs and immune evasion. Biochim Biophys Acta 1809:708–714
5. Broekema NM, Imperiale MJ (2013) miRNA regulation of BK polyomavirus replication during early infection. Proc Natl Acad Sci U S A 110:8200–8205
6. Chen Y, Bord E, Tompkins T, Miller J, Tan CS, Kinkel RP, Stein MC, Viscidi RP, Ngo LH, Koralnik IJ (2009) Asymptomatic reactivation of JC virus in patients treated with natalizumab. N Engl J Med 361:1067–1074
7. Chen CJ, Cox JE, Kincaid RP, Martinez A, Sullivan CS (2013) Divergent MicroRNA targetomes of closely related circulating strains of a polyomavirus. J Virol 87:11135–11147
8. Ferenczy MW, Marshall LJ, Nelson CD, Atwood WJ, Nath A, Khalili K, Major EO (2012) Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 25:471–506
9. Imperiale MJ (2014) Polyomavirus miRNAs: the beginning. Curr Opin Virol 7C:29–32
10. Lagatie O, Tritsmans L, Stuyver LJ (2013) The miRNA world of polyomaviruses. Virol J 10:268–288
11. Lagatie O, Van Loy T, Tritsmans L, Stuyver LJ (2014) Viral miRNAs in plasma and urine divulge JC polyomavirus infection. Virol J 11:158–166
12. Lindberg RL, Achtnichts L, Hoffmann F, Kuhle J, Kappos L (2008) Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients. J Neuroimmunol 194:153–164
13. Link A, Balaguer F, Nagasaka T, Boland CR, Goel A (2014) MicroRNA miR-J1-5p as a potential biomarker for JC virus infection in the gastrointestinal tract. PLoS ONE 9:e100036
14. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, de Gruijl TD, Würdinger T, Middeldorp JM (2010) Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A 107:6328–6333
15. Ryschkewitsch CF, Jensen PN, Major EO (2013) Multiplex qPCR assay for ultra sensitive detection of JCV DNA with simultaneous identification of genotypes that discriminates non-virulent from virulent variants. J Clin Virol 57:243–248
16. Sadiq SA, Puccio LM, Brydon EW (2010) JCV detection in multiple sclerosis patients treated with natalizumab. J Neurol 257:954–958
17. Seo GJ, Fink LH, O’Hara B, Atwood WJ, Sullivan CS (2008) Evolutionarily conserved function of a viral microRNA. J Virol 82:9823–9828
18. Skarica M, Eckstein C, Whartenby KA, Calabresi PA (2011) Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients. J Neuroimmunol 235:70–76
19. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654–659
20. Zhang S, Sroller V, Zanwar P, Chen CJ, Halvorson SJ, Ajami NJ, Hecksel CW, Swain JL, Wong C, Sullivan CS, Butel JS (2014) Viral microRNA effects on pathogenesis of polyomavirus SV40 infections in Syrian golden hamsters. PLoS Pathog 10:e1003912